Living Cancer

Mary Harris found out she was pregnant the day before she had scheduled surgery for breast cancer. This is her radio diary.

In the second hour of "The Cancer Show," the stories we tell about cancer: on stage, on the big screen, and online.

Over the last 2,500 years, cancer has shifted from a disease in the shadows to one at the center of scientific research and public discussion. In the first of two special episodes, On the Media dives deep into the way we talk about cancer: in the news, in the hospital, and in our private lives.

A woman's family is stuck with medical charges for care she received after being diagnosed with pancreatic cancer. Negotiating relief from the bills has become a part-time job for her daughter.

Dr. Harold Varmus discusses the study of genomics in cancer treatment with Brian Lehrer and The New York Times "Living With Cancer" columnist Susan Gubar fields calls on how to talk to people with cancer.

After a couple lost their young child to cancer, they found comfort in an unexpected place: by making a video game about their son.

A drug that's effective in patients with certain forms of melanoma is being tested as a treatment for other cancers whose genetic code contains an identical mutation.

After years of working as a physician, Ken Jeong quit to pursue acting. Then his wife was diagnosed with breast cancer, and he found himself needing to think like a doctor again.

Advances in cancer treatments have made some forms of the disease a chronic condition. But protracted treatment, even when successful, comes at a high personal toll for patients and their families

In "Cancer: The Emperor of All Maladies," Ken Burns and Barak Goodman tell the comprehensive story of the disease and our quest to understand it, treat it, and cure it.

Cancer treatment for kids has changed dramatically since the 1960s. Back then, doctors experimented with approaches that seemed promising but were also potentially toxic. Some survivors look back.

Medical researchers have made only modest progress treating the most common cancers since the war on cancer was declared in 1971. The disease has proved far more complicated than doctors had hoped.

Many things raise the risk for cancer, including exposure to various toxins and radiation. But our knowledge about the range of chemicals and compounds that can trigger cancer is limited.

A leading researcher in immunotherapy and one of his patients discuss the treatment and how it could radically change cancer treatment.

After being diagnosed with cancer, people often ask one question first: "How long do I have?" Doctors usually overestimate the time, and patients often don't understand it's a range, not one number.

Black men are more than twice as likely as their white counterparts to die from prostate cancer. A former patient and a doctor treating prostate cancer explains why.

Our immune systems constantly fight off disease protecting us from colds, flu and infection. An experimental treatment called immunotherapy is helping patients' immune systems fight off cancer.

When a child falls ill with cancer, many of the drugs that might help are either experimental or unapproved for use in kids.